Brief: Tang Capital Partners Reports 9.99% Passive Stake In Transcode Therapeutics As Of Sept 26- SEC Filing
26/09/2023 18:31
Sept 26 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TANG CAPITAL PARTNERS, LP REPORTS 9.99% PASSIVE STAKE IN
TRANSCODE THERAPEUTICS AS OF SEPTEMBER 26- SEC FILING
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors